2017
Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. The Lancet Global Health 2017, 5: e1123-e1132. PMID: 29025634, PMCID: PMC5640802, DOI: 10.1016/s2214-109x(17)30341-8.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisEnd TB StrategyTuberculosis servicesCatastrophic costsTB StrategyDrug-sensitive tuberculosisCatastrophic financial burdenAnnual household incomeTuberculosis careTuberculosis controlEconomic burdenTuberculosisIntervention effectsMelinda Gates FoundationHousehold incomeIndirect costsFinancial burdenExpansion of accessPatientsTotal annual household incomeTreatmentCareGates FoundationBurdenIntervention scenarios
2016
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet Global Health 2016, 4: e806-e815. PMID: 27720688, PMCID: PMC6375908, DOI: 10.1016/s2214-109x(16)30199-1.Peer-Reviewed Original ResearchConceptsEnd TB Strategy targetsPreventive therapyTuberculosis incidenceContinuous isoniazid preventive therapyGlobal tuberculosis targetsIsoniazid preventive therapySymptoms of tuberculosisActive case findingNational Tuberculosis ProgrammeEnd TB StrategyHigh-burden countriesAntiretroviral therapyLatent tuberculosisStrategy targetsTuberculosis burdenTuberculosis careTuberculosis ProgrammeTB StrategyTuberculosis transmissionHealth centersAdditional interventionsTuberculosis interventionsCase findingTuberculosis epidemiologyEpidemiological impact
2012
The impact of new tuberculosis diagnostics on transmission: why context matters
Lin HH, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin Of The World Health Organization 2012, 90: 739-747. PMID: 23109741, PMCID: PMC3471051, DOI: 10.2471/blt.11.101436.Peer-Reviewed Original ResearchConceptsNew tuberculosis diagnosticsNew diagnostic toolsPatient lossHuman immunodeficiency virus (HIV) infectionTuberculosis diagnosticsSmear-negative pulmonary tuberculosisDiagnostic toolImmunodeficiency virus infectionTreatment success rateSmear-negative casesIncidence of tuberculosisEpidemiology of tuberculosisPatient defaultPulmonary tuberculosisTuberculosis careDiagnostic pathwayTuberculosis transmissionSymptomatic individualsVirus infectionSmear microscopyTuberculosisAnnual declineDiagnosisAbsolute changeSuccess rate